Nipro Pharma to build general injectable drug facility in Ritto

Nipro Pharma is constructing a general injectable drug manufacturing building and installing production equipment at its site in Ritto, Shiga. The project has a total planned investment of ¥37.08 billion, began in July 2022, and is scheduled for completion in August 2026, increasing capacity by 47.7 million units per year.